Prot# 07-028R: Efficacy and Tolerability of Ramelteon (Rozerem) in Patients with REM Behavior Disorder and Parkinsonism: A Placebo Controlled, Double-Blind, Randomized, Pilot Study

Project: Research project

Project Details

StatusFinished
Effective start/end date2/5/082/5/11

Funding

  • Takeda Pharmaceuticals U.S.A., Inc. (07-028R)